Loading...
7733
XJPX
Market cap12bUSD
Nov 20, Last price  
1,833.00JPY
1D
-0.84%
1Q
-15.47%
Jan 2017
81.49%
Name

Olympus Corp

Chart & performance

D1W1MN
XJPX:7733 chart
P/E
28.58
P/S
1.93
EPS
64.14
Vol. 1Y
44.45%
Shs. 5Y
-2.84%
Rev. 5Y
6.71%
Div Yld LY
1.09%
Div Yld TTM
3.27%
Revenues
1.01t
+1.34%
1,061,786,000,0001,128,875,000,000980,803,000,000883,086,000,000847,105,000,000848,548,000,000743,851,000,000713,286,000,000764,671,000,000804,578,000,000740,557,000,000786,497,000,000793,862,000,000755,231,000,000730,544,000,000750,123,000,000881,923,000,000925,752,000,000997,332,000,0001,010,676,000,000
Net income
68.17b
-42.16%
47,799,000,00057,969,000,000-114,810,000,00047,763,000,0003,866,000,000-48,985,000,0008,020,000,00013,627,000,000-8,737,000,00062,594,000,00042,783,000,00057,064,000,0008,147,000,00080,288,000,00057,712,000,000115,742,000,000143,432,000,000242,566,000,000117,855,000,00068,172,000,000
CFO
100.59b
-47.19%
108,400,000,00089,006,000,00041,628,000,00076,245,000,00030,469,000,00030,889,000,00025,233,000,00072,388,000,00066,811,000,00048,621,000,000102,052,000,00095,146,000,00066,943,000,000133,544,000,000124,122,000,000169,729,000,00098,490,000,00042,365,000,000190,463,000,000100,585,000,000
Dividend
Mar 30, 202730 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Olympus Corporation, a global enterprise headquartered in Tokyo, Japan, manufactures and distributes high-precision machinery and instrumentation worldwide. The company, originally established in 1919 as Olympus Optical Co., Ltd., adopted its current name in October 2003. Its extensive operations are structured into four primary divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and a segment designated as "Others." The Endoscopic Solutions division specializes in developing and providing gastrointestinal and surgical endoscopes, comprehensive endoscopy systems, and associated repair services. The Therapeutic Solutions segment focuses on products for urology, gynecology, and ear, nose, and throat (ENT) procedures, alongside endo-therapy devices, energy-based surgical tools, and disposable surgical instruments. Within Scientific Solutions, Olympus supplies biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing (NDT) equipment, and X-ray fluorescence (XRF) analyzers. The "Others" segment encompasses biomedical materials and orthopedic equipment. Beyond these core areas, the company also offers a broader array of medical devices, including surgical microscopes, endoscope reprocessing units, electrosurgical tools, and respiratory-endotherapy devices, complemented by system integration and ongoing maintenance services.

Related entities

Subsidiaries
OLYMPUS GLOBAL TREASURY SERVICES LIMITED

Key people

Bob White
President, Chief Executive Officer, Representative Executive Officer · since 2025
Shigeto Ohtsuki
Executive Officer, Chief Human Resources Officer · since 2023
Syed Naveed
Executive Officer, Chief Technology Officer · since 2025
Simone Berger
Executive Officer, Chief Human Resources Officer · since 2026
Keith Boettiger
Executive Officer · since 2026
John Chepel
Executive Officer, Chief Medical Officer · since 2024
Frank Drewalowski
Executive Officer · since 2025
Masahito Goto
Executive Officer · since 2022
Kota Ishibiki
Executive Officer, President of Subsidiary · since 2025
Tatsuya Izumi
Executive Officer, Chief Financial Officer · since 2024
Hironobu Kawano
Executive Officer · since 2021
Gabriela Kaynor
Executive Officer, Chief Strategy Officer · since 2024
Hidenobu Kimura
Deputy Chief Technology Officer, Executive Officer · since 2025
Stephen Kneebone
Executive Officer · since 2022
Seiji Kuramoto
Executive Officer · since 2022
Pedro Lazaro
Deputy Chief Financial Officer, Executive Officer · since 2025
Gabriel Mchugh
Executive Officer · since 2025
Tetsuaki Mori
Executive Officer · since 2025
Takeshi Ogura
Executive Officer, Deputy Chief Quality Officer · since 2025
Tomohisa Sakurai
Executive Officer · since 2024
IPO date
May 16, 1949
Employees
32,844
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
石川町2951番地
八王子市, 13 192-8507
JP
Other language
Olympus Corp.

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT